January 23, 2024 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announced that an independent 

January 23, 2024 — Focused on delivering the latest scientific advancements and new treatments in cerebrovascular diseases and brain health science from around the world, this year's International Stroke Conference, ISC 2024, will be held Feb. 7-9 in Phoenix, Arizona.

January 22, 2024 — A physician-scientist from Massachusetts researching whether chemicals naturally occurring in foods could help treat heart disease, a genetics expert from Pennsylvania exploring the molecular mechanisms of lipid metabolism and cardiovascular diseases and a California-based professor of cardiovascular medicine studying how 

January 19, 2024 — Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023.

January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrial fibrillation (AFib). Over 30 patients were recently treated in Australia as part of Abbott's Volt CE Mark study, a pre-market, multi-center clinical study designed to evaluate the safety and effectiveness of Abbott's Volt PFA System.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now